article · Journal of Natural Products
Fungal-derived natural products continue to play a pivotal role in the discovery of drug agents for human, veterinary, and general agricultural use. The fungus <i>Neodidymelliopsis negundinis</i> presents a significant saprobic ascomycete whose metabolites remained hitherto unstudied. Herein we report the isolation of eight unprecedented secondary metabolites named neodidymelliosides A and B (<b>1</b> and <b>2</b>), neodidymelliol A (<b>3</b>), and neodidymellioic acids A-E (<b>4</b>-<b>8</b>) produced by the submerged cultures of the fungus. Compound <b>1</b> proved to be the most active compound, with IC<sub>50</sub> values ranging between 4.8 and 8.8 μM against KB3.1 (cervix), PC-3 (prostate), MCF-7 (breast), SKOV-3 (ovary), A431 (skin), and A549 (lung) cell lines. Compound <b>1</b> revealed significant inhibition of <i>Staphylococcus aureus</i> and <i>Candida albicans</i> biofilms.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1021/acs.jnatprod.3c01094
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.